Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study In Patients With Liver Predominant Unresectable mCRC Receiving Treatment With LifePearl Microspheres Loaded With Irinotecan

NCT02547480 is registered in ClinicalTrials.gov with Terumo Europe N.V. as lead sponsor.

NCT NCT02547480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02547480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study In Patients With Liver Predominant Unresectable mCRC Receiving Treatment With LifePearl Microspheres Loaded With Irinotecan
Lead sponsor
Terumo Europe N.V.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
September 19, 2017
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mcrc, metastatic colorectal cancer